Immuno-Biological Laboratories Co., Ltd. (4570.T)
- Previous Close
513.00 - Open
513.00 - Bid --
- Ask --
- Day's Range
513.00 - 528.00 - 52 Week Range
356.00 - 603.00 - Volume
105,700 - Avg. Volume
67,291 - Market Cap (intraday)
4.918B - Beta (5Y Monthly) -0.00
- PE Ratio (TTM)
20.66 - EPS (TTM)
25.56 - Earnings Date May 14, 2025
- Forward Dividend & Yield 12.00 (2.34%)
- Ex-Dividend Date Mar 30, 2026
- 1y Target Est
--
Immuno-Biological Laboratories Co., Ltd. engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide. The company offers ELILSA, an assay kit to quantitatively measure targeted substances; and support research services on Alzheimer's disease, metabolic syndrome, and cancer, as well as customized services for production of customized antibodies and development of ELISA systems. It also provides LipoSEARCH, a customized services for profiling and analyzing of lipoprotein through gel-filtration high performance liquid chromatography method that can profile various clinical samples, such as tiny plasma or serum samples from both small animals and human beings for broad range of research fields including lipid metabolism, development of drugs for life-style related diseases, development of functional supplemental foods, and clinical studies. In addition, the company offers LipoTEST, a support tool for diagnostic and health checks at animal clinics; and customized biomarker testing services for Life-style related diseases. Further, it operates protein production business using transgenic silkworms for manufacturing of antibodies for research reagents and diagnostic products; human collagen for cosmetic materials; development of proteins for use in drugs; and other proteins production. The company was incorporated in 1982 and is headquartered in Fujioka, Japan.
www.ibl-japan.co.jpRecent News: 4570.T
View MorePerformance Overview: 4570.T
Trailing total returns as of 5/27/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4570.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4570.T
View MoreValuation Measures
Market Cap
4.78B
Enterprise Value
4.24B
Trailing P/E
20.64
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.34
Price/Book (mrq)
3.57
Enterprise Value/Revenue
4.74
Enterprise Value/EBITDA
25.17
Financial Highlights
Profitability and Income Statement
Profit Margin
25.70%
Return on Assets (ttm)
7.54%
Return on Equity (ttm)
17.92%
Revenue (ttm)
969M
Net Income Avi to Common (ttm)
249M
Diluted EPS (ttm)
25.56
Balance Sheet and Cash Flow
Total Cash (mrq)
825M
Total Debt/Equity (mrq)
13.47%
Levered Free Cash Flow (ttm)
55M